Fraud Investigation
SMS Pharmaceuticals Detects Alleged Fraudulent Claims on 85,000 Physical Shares; Criminal Case Registered
NSE
smspharma
BSE
532815
SMS Pharmaceuticals Limited has disclosed the detection of an alleged fraudulent share claim scheme involving physical share certificates belonging to genuine shareholders. Following an internal verification, the company identified 85,000 equity shares across seven original shareholders that were allegedly claimed using forged documents and impersonation. The company has filed a complaint with the Economic Offences Wing (EOW), Hyderabad, and a case has been registered for further investigation.
PRICE-SENSITIVE TRIGGER
Event: Detection of suspected fraudulent transfer and claim of physical share certificates through forged documentation and impersonation.
Type: Fraud Investigation
Impact: Negative
Immediate Effect: The company has initiated legal proceedings and referred the matter to law enforcement authorities. An EOW case has been registered and investigations are underway.
Key Metrics:
- Equity shares involved: 85,000 shares
- Number of affected original shareholders: 7
- Financial impact disclosed: Not quantified
- Revenue impact: Not disclosed
- EBITDA impact: Not disclosed
- PAT impact: Not disclosed
- Margin impact: Not disclosed
- QoQ movement: Not applicable
- YoY movement: Not applicable
- Segment impact: Not disclosed
Highlight:
- SMS Pharmaceuticals identified alleged fraudulent claims involving 85,000 physical equity shares belonging to seven genuine shareholders.
What Happened ?
The company received a request from a shareholder for KYC updation relating to physical shareholdings through its Registrar and Share Transfer Agent (RTA). During the verification process, SMS Pharmaceuticals discovered that the concerned shares had already been claimed by another individual allegedly impersonating the original shareholder.
A subsequent internal review of documentation and transfer records revealed indications of forged and fabricated documents used for claiming shares. The company further observed a recurring pattern involving similar documentation and closely linked addresses among the alleged claimants.
The matter was escalated to the Stakeholders Relationship Committee and the Board of Directors for review and further action.
Key Details
Alleged Fraudulent Share Claims:
- Company received a KYC updation request from a genuine shareholder.
- Verification revealed the shares had already been claimed by another person.
- Internal review indicated alleged use of forged and fabricated documents.
- Similar document patterns were observed across multiple cases.
- Addresses of alleged claimants were either identical or located in nearby areas.
- Company identified a common modus operandi in the suspected fraudulent transfers.
- Total of 85,000 physical equity shares were found to be affected.
- Shares belonged to seven original shareholders.
- Matter was placed before the Stakeholders Relationship Committee and the Board.
Note:
- The company’s findings are based on a prima facie review and the matter is now under investigation by law enforcement authorities.
Legal and Regulatory Action:
- Stakeholders Relationship Committee advised immediate legal action.
- Company filed a police complaint against persons involved.
- Complaint was lodged before the Economic Offences Wing (EOW), Central Crime Station, Hyderabad.
- Preliminary inquiry was conducted by authorities.
- A formal case has been registered for detailed investigation.
- Company has stated that further material developments will be disclosed as required.
Note:
- The investigation remains ongoing and no final determination has yet been made by the authorities.
Risk Analysis
Summary:
- The incident highlights operational and shareholder-record risks associated with legacy physical share certificates. While no direct business impact has been reported, the matter may result in legal proceedings and administrative actions until investigations are completed.
Key Risks:
- Potential legal disputes relating to ownership of physical shares.
- Risk of additional historical cases being identified.
- Regulatory scrutiny if wider fraudulent activity is uncovered.
- Administrative and legal costs associated with investigations.
- Reputational concerns relating to shareholder protection mechanisms.
Worst Case Scenario:
- If investigations reveal a broader pattern of fraudulent transfers, additional shareholders could be affected, potentially leading to prolonged litigation and regulatory intervention.
Risk Level: Medium
Company Commentary
- The company conducted detailed verification of documents and transfer records.
- The Stakeholders Relationship Committee recommended filing a police complaint.
- A complaint has been filed before the Economic Offences Wing, Hyderabad.
- An EOW case has been registered following preliminary inquiry.
- SMS Pharmaceuticals remains committed to protecting shareholder interests.
- Appropriate legal and regulatory actions will be pursued.
- Further material developments will be disclosed from time to time.
Official Exchange Filing: SMS Pharmaceuticals Limited